ARCHIVES

NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments

This article is from The Cancer Letter archive.

Vol. 11 No. 12 | March 22, 1985

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

January 24, 2014

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

NCI Budget for FY 1977 Would Halt New Research

January 23, 1976

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

November 28, 2008

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

May 18, 2001

Lasagna Committee Urges Medicare Payment for Experimental Drugs, Care

September 29, 1989